A detailed history of Mach 1 Financial Group, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Mach 1 Financial Group, LLC holds 13,313 shares of CSTL stock, worth $226,587. This represents 0.09% of its overall portfolio holdings.

Number of Shares
13,313
Holding current value
$226,587
% of portfolio
0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$18.76 - $32.72 $249,751 - $435,601
13,313 New
13,313 $266,000
Q3 2023

Oct 17, 2023

BUY
$13.28 - $20.3 $345,731 - $528,490
26,034 New
26,034 $439,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $448M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Mach 1 Financial Group, LLC Portfolio

Follow Mach 1 Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mach 1 Financial Group, LLC with notifications on news.